Insulin degludec (Tresiba)
Insulin Degludec (Tresiba) delivers ultra-long-acting blood sugar control for individuals managing diabetes. It ensures steady insulin release over 24 hours or more, helping maintain stable glucose levels with reduced risk of fluctuations. Doctors prescribe this advanced insulin therapy for both Type 1 and Type 2 diabetes to improve glycemic control and reduce complications. Its flexible dosing schedule allows patients to take it at convenient times without compromising effectiveness. Designed for consistent performance, this insulin supports better daily management, improved energy levels, and enhanced quality of life, making it a reliable choice for long-term diabetes care.
Description
Insulin Degludec (Tresiba) offers advanced and reliable blood sugar management by delivering a steady and prolonged insulin effect, making it a preferred treatment option for individuals living with diabetes. This ultra-long-acting insulin actively regulates glucose levels by mimicking the body’s natural basal insulin secretion, ensuring consistent control throughout the day and night. It plays a critical role in maintaining stable blood sugar levels, reducing the risk of both hyperglycemia and hypoglycemia, and supporting overall metabolic balance.
Healthcare providers emphasize individualized dosing to achieve optimal results. They determine the appropriate dosage based on the patient’s condition, lifestyle, and response to treatment. Patients administer the injection subcutaneously, usually once daily, making it convenient and easy to integrate into daily routines. Its flexible dosing schedule allows administration at different times of the day without compromising its effectiveness, which adds convenience for patients with busy or unpredictable lifestyles.
In addition to glycemic control, this treatment supports long-term health outcomes by helping prevent diabetes-related complications such as nerve damage, kidney issues, and cardiovascular conditions. Consistent blood sugar management plays a vital role in preserving organ function and maintaining overall well-being. Medical professionals often recommend combining insulin therapy with a balanced diet, regular exercise, and routine monitoring for best results.
- Product Name: Insulin Degludec (Tresiba)
- Category: Long-Acting Basal Insulin
- Used For: Management of Type 1 and Type 2 Diabetes
- Dosage Form: Solution for Injection (Prefilled Pen / Vial)
- Strengths Available: 100 units/mL, 200 units/mL
- Route of Administration: Subcutaneous Injection
- Onset of Action: Approximately 1 hour
- Duration of Action: Up to 42 hours (ultra-long acting)
- Dosing Frequency: Once daily (flexible timing)
- Mechanism of Action: Provides steady insulin release to control blood glucose levels
- Suitable For: Adults and children (as prescribed by a doctor)
- Storage Conditions: Refrigerate at 2°C to 8°C; do not freeze
